Supporting our in vitro findings, we observed increased platelet proteasome activity in platelets of patients with sepsis by fluorescent substrate cleavage as well as significantly increased cleavage of the proteasome substrate Talin-1 in the sepsis population ex vivo. This evidence concerns the gene TLN1 and Sepsis.